top of page
Search

Paraneoplastic Syndromes (Lung) MRCP Part 1

TL;DR

Resp: Paraneoplastic Syndromes (Lung Specific) are a high-yield topic in MRCP Part 1, commonly tested via tumour–hormone associations and neurological syndromes. Small cell lung carcinoma is the key culprit, linked to SIADH, ectopic ACTH, and Lambert–Eaton syndrome. Focus on pattern recognition—matching clinical features with tumour type. Mastering these links can quickly secure marks in the exam.


Why this matters

Paraneoplastic syndromes are remote effects of malignancy, mediated by ectopic hormone production, immune cross-reactivity, or cytokine release. In lung cancer, these syndromes are particularly important for MRCP Part 1 because they are:

  • Frequently tested in single-best-answer format

  • Often clinically distinctive and recognisable

  • Strongly linked to specific tumour histologies

For candidates, this is a high-yield topic where a small set of associations yields disproportionately high returns.

For broader preparation, review the MRCP Part 1 overview.


Core sections

1. Classification Overview

Paraneoplastic syndromes in lung cancer are broadly classified into:

  1. Endocrine

  2. Neurological

  3. Musculoskeletal

  4. Haematological

  5. Dermatological

However, for MRCP Part 1, endocrine and neurological syndromes dominate questions.

2. High-Yield Associations (Core Table)

Syndrome

Mechanism

Associated Lung Cancer

Key Clinical Clue

SIADH

Ectopic ADH secretion

Small cell

Euvolaemic hyponatraemia

Ectopic Cushing’s

ACTH secretion

Small cell

Hypokalaemia, alkalosis

Lambert–Eaton syndrome

Anti–Ca²⁺ channel antibodies

Small cell

Weakness improves with use

Hypercalcaemia

PTHrP secretion

Squamous cell

Raised Ca, low PTH

Hypertrophic osteoarthropathy

Likely VEGF-mediated

Adenocarcinoma

Clubbing + periostitis

👉 This table represents the core exam framework.

3. The Five Most Tested Syndromes

A. SIADH (Small Cell Lung Cancer)

  • Due to ectopic ADH production

  • Features:

    • Hyponatraemia

    • Low serum osmolality

    • Concentrated urine

Exam insight: Often asymptomatic—detected via routine bloods.

B. Ectopic ACTH Syndrome

  • Leads to rapid-onset Cushing’s syndrome

  • Features:

    • Severe hypokalaemia

    • Resistant hypertension

    • Metabolic alkalosis

Key point: Absence of classic Cushingoid appearance is common.

C. Lambert–Eaton Myasthenic Syndrome

  • Autoimmune attack on presynaptic calcium channels

  • Features:

    • Proximal muscle weakness

    • Improves with activity

    • Reduced or absent reflexes

Contrast: Myasthenia gravis worsens with use.

D. Hypercalcaemia (Squamous Cell Carcinoma)

  • Mediated by PTHrP

  • Features:

    • Hypercalcaemia

    • Suppressed PTH

    • No bone metastases required

E. Hypertrophic Osteoarthropathy

  • Features:

    • Digital clubbing

    • Joint pain

    • Periosteal new bone formation

4. Additional High-Yield Points

  • Small cell lung carcinoma = neuroendocrine origin

  • Most paraneoplastic syndromes = small cell

  • SIADH = most tested endocrine syndrome

  • LEMS may precede cancer diagnosis

  • Syndromes often improve after tumour treatment

  • Always suspect malignancy in unexplained endocrine abnormalities

  • Neurological syndromes are immune-mediated

  • Hypercalcaemia is common in malignancy but mechanism varies


Practical examples / mini-cases

MCQ

A 60-year-old man with a heavy smoking history presents with confusion. Blood tests show sodium of 118 mmol/L. He is clinically euvolaemic. Chest imaging reveals a central lung mass.

Most likely mechanism?

A. PTHrP secretionB. ADH secretionC. ACTH secretionD. Renal sodium loss

Answer: B. ADH secretion

Explanation:

  • Euvolaemic hyponatraemia strongly suggests SIADH

  • Classic association with small cell lung carcinoma

  • Key diagnostic clue: low serum osmolality with inappropriately concentrated urine

👉 Practise more questions via Free MRCP MCQs.


Common pitfalls (5 bullets)

  • Confusing Lambert–Eaton with myasthenia gravis

  • Assuming hypercalcaemia implies bone metastases

  • Missing SIADH due to subtle presentation

  • Expecting typical Cushingoid features in ectopic ACTH

  • Forgetting adenocarcinoma association with clubbing


Practical study-tip checklist

  • Memorise the core association table

  • Use pattern-based learning

  • Focus on mechanism + tumour pairing

  • Reinforce with MCQs regularly

  • Revise using spaced repetition

👉 Test yourself with a timed Start a mock test.


Medical student revising paraneoplastic syndromes for MRCP Part 1 with notes and study materials

FAQs

1. Which lung cancer most commonly causes paraneoplastic syndromes?

Small cell lung carcinoma is the most commonly associated, particularly with endocrine and neurological syndromes.

2. What is the most commonly tested syndrome in MRCP Part 1?

SIADH is the most frequently tested due to its classic biochemical pattern.

3. How can you differentiate Lambert–Eaton from myasthenia gravis?

Lambert–Eaton improves with repeated use and affects presynaptic channels, while myasthenia worsens with activity.

4. Why does squamous cell carcinoma cause hypercalcaemia?

It produces PTH-related peptide, mimicking parathyroid hormone effects.

5. Are paraneoplastic syndromes reversible?

Many improve or resolve with treatment of the underlying malignancy.


Ready to start?

Paraneoplastic syndromes are a high-yield, pattern-recognition topic in MRCP Part 1. Master the associations, practise MCQs, and integrate them into your revision plan.


Sources

 
 
 

Comments


bottom of page